The incidence of disseminated histoplasmosis in the United States is increasing, especially among immunocompromised patients.1 Conventional treatment consists of amphotericin B, whose
Harten P, Baron Y, Euler HH. Liposomal Amphotericin B Therapy in Disseminated Histoplasmosis. Arch Intern Med. 1995;155(14):1556. doi:10.1001/archinte.1995.00430140136020
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: